Partnership expands access to Gauss’s proprietary, EUA-pending COVID-19 rapid antigen test that can be self-administered at-home with results processed on a smartphone within minutes. Ro will complement the cash-pay test with support of healthcare practitioners through its telehealth platform.
Read more here.
The post [RO in PR Newswire] Ro and Gauss Partner to Offer Rapid, At-Home COVID-19 Testing Nationwide appeared first on OurCrowd Blog.
(Visited 4 times, 1 visits today)